Partner Content Partner Content Key Reasons to attend SMi’s 3D Cell Culture Conference 2020 Key Reasons to attend SMi’s 3D Cell Culture
Views & Analysis Bioprinting organs and the future of healthcare The artificial creation of human skin, tissue and internal organs may sound like something from the distant future, but much of it is happening right now in research facilities around the g
Partner Content Partner Content Complex Co-Cultured Spheroids to Validate Tumour Models in M... Complex Co-Cultured Spheroids in Cancer Research
Partner Content Partner Content 3D Cell Culture 2018: Exclusive New Interviews Released 3D Cell Culture Interviews Released
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
